Sto SE & Co. KGaA (0G5B)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 101.60 |
|---|---|
| 52-week range | 91.00 – 130.40 |
| Return, 1 month / 3 months | +1.2% / +7.9% |
| Return, 1 year / 3 years | −17.4% / −12.0% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 28.2% |
| Worst drawdown (1 year) | -30.7% |
| Average daily value traded | 0.02M EUR |
| Dividend yield | 0.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sto SE & Co. KGaA is a German manufacturer of building products, based in Stuehlingen in the south of the country. The company makes exterior wall insulation and facade systems, renders, paints and related construction materials. Its customers are mainly architects, contractors, distributors and building professionals who use its products for new construction and for renovating existing buildings. Sto also supplies interior products such as acoustic and decorative finishes for walls and ceilings.
The shares are listed on the London Exchange in UK under the code 0G5B, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sto SE & Co. KGaA (0G5B) trades on the London Exchange in UK. It last closed at EUR 101.60 on 23 October 2026.
Its price-based Market X-Ray is 39 out of 100 (a weak price profile), ranking 2,701 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 17.4% and over the last three months it rose 7.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 35 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -4.7% | ||
| From 52-week high | -22.1% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 7.9% | ||
| 6-month return | -7.4% | ||
| 12-month return, skipping the last month | -18.4% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.7% | ||
| Liquidity | 17 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M EUR | ||
| Zero-volume days | 20.0% | ||
| Income | 22 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.3% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.6% |
|---|---|
| 1 month | +1.2% |
| 3 months | +7.9% |
| 6 months | −7.4% |
| 1 year | −17.4% |
| 3 years | −12.0% |
| 5 years | −45.2% |
Signals
| 50-day / 200-day average | 99.26 / 106.58 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.59 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Jun 2026 | EUR 0.3100 |
| 19 Jun 2025 | EUR 3.0000 |
| 20 Jun 2024 | EUR 0.3100 |
| 22 Jun 2023 | EUR 0.3100 |
| 23 Jun 2022 | EUR 4.6900 |
| 17 Jun 2021 | EUR 0.3100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.